PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.58%
Negative revenue growth while JHX stands at 6.59%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-34.45%
Negative gross profit growth while JHX is at 13.05%. Joel Greenblatt would examine cost competitiveness or demand decline.
144.25%
Positive EBIT growth while JHX is negative. John Neff might see a substantial edge in operational management.
144.25%
Positive operating income growth while JHX is negative. John Neff might view this as a competitive edge in operations.
-41.75%
Negative net income growth while JHX stands at 105.45%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-99.72%
Negative EPS growth while JHX is at 105.67%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-99.72%
Negative diluted EPS growth while JHX is at 105.67%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
330.40%
10Y revenue/share CAGR above 1.5x JHX's 83.51%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
206.03%
5Y revenue/share CAGR above 1.5x JHX's 83.51%. David Dodd would look for consistent product or market expansions fueling outperformance.
86.77%
3Y revenue/share CAGR 1.25-1.5x JHX's 69.93%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
519.70%
Below 50% of JHX's 3640.04%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
431.48%
Below 50% of JHX's 3640.04%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
164.38%
3Y net income/share CAGR above 1.5x JHX's 1.05%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
SG&A growth well above JHX's 4.44%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.